BIOMAT Database Logo BIOMAT Database Logo

[Treatment of rheumatoid arthritis with cyclophosphamide (Endoxan)]. 1971

N V Jarlov, and K Sorensen

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

N V Jarlov, and K Sorensen
[Endoxan in the treatment of psoriatic arthritis and rheumatoid arthritis].
January 1972, Reumatologia,
N V Jarlov, and K Sorensen
Cyclophosphamide treatment of rheumatoid arthritis.
October 1969, Arthritis and rheumatism,
N V Jarlov, and K Sorensen
[Ambulatory treatment of rheumatoid arthritis with cyclophosphamide].
July 1972, Polskie Archiwum Medycyny Wewnetrznej,
N V Jarlov, and K Sorensen
[Effect of cyclophosphamide (Endoxan) on experimental arthritis in rabbits].
January 1978, Zeitschrift fur Rheumatologie,
N V Jarlov, and K Sorensen
[Cyclophosphamide in the treatment of rheumatoid arthritis].
March 1972, Minerva medica,
N V Jarlov, and K Sorensen
Cyclophosphamide vs. conservative treatment of rheumatoid arthritis.
October 1968, Arthritis and rheumatism,
N V Jarlov, and K Sorensen
[Up-to-date results of treatment with cyclophosphamide (endoxan)].
January 1967, Polskie Archiwum Medycyny Wewnetrznej,
N V Jarlov, and K Sorensen
[CLINICAL TRIALS WITH CYCLOPHOSPHAMIDE (ENDOXAN)].
July 1963, Geneeskundige gids,
N V Jarlov, and K Sorensen
Cyclophosphamide (Endoxan; Procytox).
April 1960, Canadian Medical Association journal,
N V Jarlov, and K Sorensen
[Long term treatment of rheumatoid arthritis with azathioprine and cyclophosphamide].
January 1969, Verhandlungen der Deutschen Gesellschaft fur Rheumatologie,
Copied contents to your clipboard!